Cargando…
Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways
OBJECTIVE: Human oral squamous cell carcinoma (OSCC) is a major cause of mortality and morbidity worldwide. There is an urgent need to identify bioactive molecules and potential target genes that could inhibit carcinogenesis for OSCC therapy. Fisetin (3,7,3′,4′-tetrahydroxyflavone), a naturally occu...
Autores principales: | Li, Yanshu, Jia, Shiheng, Dai, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049269/ https://www.ncbi.nlm.nih.gov/pubmed/32158195 http://dx.doi.org/10.2147/DDDT.S229270 |
Ejemplares similares
-
MAGE-A11 Expression Predicts Patient Prognosis in Head and Neck Squamous Cell Carcinoma
por: Jia, Shiheng, et al.
Publicado: (2020) -
Crosstalk between Fisetin-induced Apoptosis and Autophagy in Human Oral Squamous Cell Carcinoma
por: Park, Bong-Soo, et al.
Publicado: (2019) -
Linc01234 promotes cell proliferation and metastasis in oral squamous cell carcinoma via miR-433/PAK4 axis
por: Liu, Deyu, et al.
Publicado: (2020) -
GL-1196 Suppresses the Proliferation and Invasion of Gastric Cancer Cells via Targeting PAK4 and Inhibiting PAK4-Mediated Signaling Pathways
por: Zhang, Jian, et al.
Publicado: (2016) -
The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways
por: Youns, Mаhmoud, et al.
Publicado: (2017)